BiotechTube
Home/Immunic/Dr. Daniel Vitt
DD

Dr. Daniel Vitt

President, CEO, and Chairman of the Management Board

Immunic

Therapeutic Areas

Multiple SclerosisInflammatory Bowel DiseaseAutoimmune Diseases

Immunic Pipeline

DrugIndicationPhase
Vidofludimus calcium (IMU-838)Relapsing-Remitting Multiple Sclerosis (RRMS)Phase 3
IMU-856Celiac Disease / GI Barrier FunctionPhase 1b
IMU-935 / IMU-856Psoriasis / Inflammatory DiseasesPreclinical / Phase 1

Leadership Team at Immunic

DA
Dr. Andreas Muehler
Chief Medical Officer
DD
Dr. Duane Nash
Chairman of the Supervisory Board
DH
Dr. H. Daniel Perez
Board Member
View full Immunic profile